Results 101 to 110 of about 10,763,224 (335)

Non-Uniform Information Access in Collaborative Information Retrieval

open access: yesACM SIGIR Forum, 2018
Although there has been a great deal of research into Collaborative Information Retrieval/Seeking (CIR/S), the majority has assumed that team members in a collaborative search team always have the same level of unrestricted access to information. However, observations from different domains such as healthcare, business, government, etc.
openaire   +2 more sources

A large‐scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression‐free survival

open access: yesMolecular Oncology, EarlyView.
There is an unmet need in metastatic breast cancer patients to monitor therapy response in real time. In this study, we show how a noninvasive and affordable strategy based on sequencing of plasma samples with longitudinal tracking of tumour fraction paired with a statistical model provides valuable information on treatment response in advance of the ...
Emma J. Beddowes   +20 more
wiley   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

open access: yesMolecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau   +11 more
wiley   +1 more source

Open Access to Information. Free Licenses [PDF]

open access: yesRevista Română de Biblioteconomie și Știința Informării, 2017
In order to clarify perspectives that go beyond the limitations of copyright law, Law no. 8/1996 on copyright and neighbouring rights, we will address below several concepts regarding free licenses, the context in which creative licenses emerged, how to ...
Ionela Maria Bârsan
doaj  

Diversity, equal access and information

open access: yesJournal of Innovation in Health Informatics, 2003
The overall aim of diversity is to ensure that every individual, whatever their differences, has fair and equitable access to health care and to employment based on clinical need and merit. This has advantages for staff by allowing them to give of their best and for patients by better identifying and meeting their needs. Evidence shows that individuals
openaire   +4 more sources

Multi‐omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

open access: yesMolecular Oncology, EarlyView.
This study highlights the importance of multi‐omic analyses in characterizing colorectal cancers. Indeed, our analysis revealed a rare CMS1 exhibiting dampened immune activation, including reduced PD‐1 expression, moderate CD8+ T‐cell infiltration, and suppressed JAK/STAT pathway.
Livia Concetti   +10 more
wiley   +1 more source

Barriers to Publish in Open Access Journals According to Medical researchers

open access: yesمدیریت اطلاعات سلامت, 2015
Introduction: The Open Access Movement has been one of the best ways that can facilitate information flow. One of the representations of the Open Access Movement is Open Access Journals.
Leila Khalili
doaj  

Access to information and oncofertility consultation for young women with breast cancer: a population-based study. [PDF]

open access: yesSci Rep, 2023
Martinet-Kosinski F   +5 more
europepmc   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy